CTOs on the Move

OncoGenex

www.OncoGenex.com

 
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in ...
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

American Society of Anesthesiologists

The American Society of Anesthesiologists is an educational, research and scientific association of physicians organized to raise the standards of the medical practice of anesthesiology and to improve patient care.

Morristown Manor

Morristown Manor is a Morristown, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accelerate Sports

Sports Facility | Whitesboro, NY

Synapse Medical Communications

Synapse Medical Communications is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Synapse Medical Communications, please visit www.synapseny.com

Zitter

Zitter Health Insights is a market-leading business intelligence firm serving life science companies, specialty pharmacies and managed healthcare organizations focused on optimizing patient access to pharmaceuticals. The company offers the nation`s largest payer research panel and the largest database of prior authorization policies. The average panel member represents 1 million+ covered lives and the research portfolio covers the entire spectrum of payer-influenced entities. Insights are generated primarily in multi-client subscription formats including: Managed Care Oncology Index, Managed Care Biologics and Injectables Index, Managed Care Benefit Design Index, Prior Authorization Tracking Tool, Managed Care Message Monitor, Co-Pay Offset Monitor, and P&T Perspective. Analysis is conducted for more than 250 manufacturers, 150 therapeutic areas and 1,000 products.